Boston, United States
The company's mission is to deliver a modern, intuitive, and integrated software platform that reimagines clinical trials for enhanced quality, speed, and patient-centricity. CRIO's system prioritizes data security and integrity by delivering built-in compliance across various global regulations like 21 CFR 11, ICH-GCP, GDPR, and HIPAA.
CRIO serves as an enterprise tool for clinical trial management for research sites while offering a single data platform for centralized monitoring to sponsors and CROs. Their software eliminates the inefficiencies and potential errors associated with traditional binders for source data capture. By employing autofill and data validation tools, CRIO effectively reduces protocol deviations and saves time. Moreover, the platform offers features like patient scheduling, recruiting, and financial management.
Since its establishment in 2015, CRIO has become a prominent player in data analytics and information technology, with its headquarters located in the United States. The company's dedication to innovation and efficiency has positioned it as a leader in eSource technology, making it an attractive prospect for potential investors.
